Citadel Advisors - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 89 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$409,000
-9.1%
653,993
+22.7%
0.00%
Q3 2019$450,000
+71.8%
532,969
+37.0%
0.00%
Q2 2019$262,000
-44.6%
388,900
-32.6%
0.00%
Q1 2019$473,000
-59.8%
576,988
-21.6%
0.00%
Q4 2018$1,178,000
-56.6%
736,281
-10.3%
0.00%
-100.0%
Q3 2018$2,716,000
+412.5%
820,414
+249.6%
0.00%
Q2 2018$530,000
+147.7%
234,697
+218.4%
0.00%
Q1 2018$214,000
-91.3%
73,700
-91.6%
0.00%
-100.0%
Q4 2017$2,449,000
+1055.2%
877,720
+1413.3%
0.00%
Q3 2017$212,000
+146.5%
58,000
+49.8%
0.00%
Q2 2017$86,000
+1333.3%
38,718
+252.5%
0.00%
Q1 2017$6,0000.0%10,983
+2.6%
0.00%
Q4 2016$6,000
-89.3%
10,700
-82.7%
0.00%
Q3 2016$56,000
+124.0%
61,887
+125.4%
0.00%
Q1 2016$25,000
+19.0%
27,461
+61.3%
0.00%
Q4 2015$21,000
+75.0%
17,028
+73.8%
0.00%
Q3 2015$12,000
-82.1%
9,799
-74.9%
0.00%
Q2 2015$67,000
+1575.0%
39,039
+950.0%
0.00%
Q3 2014$4,000
-88.2%
3,718
-72.7%
0.00%
Q2 2013$34,00013,5970.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Greylock XI GP Limited Partnership 584,004$1,068,000100.00%
GREAT POINT PARTNERS LLC 2,325,000$4,255,0001.89%
Sarissa Capital Management LP 2,570,759$4,704,0001.60%
Deer VI & Co. LLC 675,242$1,236,0000.68%
Palo Alto Investors LP 1,200,800$2,197,0000.16%
Baupost Group 3,829,350$7,008,0000.11%
Gruss Capital Management LP 533,253$976,0000.05%
Granahan Investment Management 676,451$1,238,0000.04%
Fore Research & Management, LP 674,200$1,233,0000.04%
TFS CAPITAL LLC 210,369$385,0000.03%
View complete list of AVEO PHARMACEUTICALS INC shareholders